Henry Ford Medical Center
Detroit, Michigan 48202
We've found
5 trials
at this facility
Triple Negative Breast Cancer Clinical Trial
Updated: 12/31/1969
Study of Adagloxad Simolenin (OBI-822) and OBI-821 Versus Placebo Treatment for High Risk Early Stage Triple Negative Breast Cancer Patients (TNBC) Following Neoadjuvant or Adjuvant Chemotherapy.
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Diabetes Mellitus, Type 2 Clinical Trial
Updated: 12/31/1969
Type 2 Diabetes (T2D) Basal Insulin Users: The Mobile Study (MOBILE)
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Advanced/Metastatic Solid Malignancies Clinical Trial
Updated: 12/31/1969
IBI308 in Subjects With Advanced/Metastatic Solid Malignancies
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Coronary Artery Disease Clinical Trial
Updated: 1/4/2016
Prospective Global Registry for the Study of Chronic Total Occlusion Intervention
Status: Enrolling
Updated: 1/4/2016
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Updated: 12/31/1969
Transplantation of Ex Vivo Expanded, UCB-derived, Stem & Progenitor Cells vs. Unmanipulated UCB for HM Patients
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials